Research & Development

91天天草台湾妹热热撸影音先锋日夜撸影音先锋北京闷热继续最高气温32℃ 夜间西部北部有雷阵雨

發布時間︰

  小冬瓜︰見笑了各位,@qz家的小天使是我們家披皮高級黑,並不代表廣大qz家粉絲立場。   “喂。”91天天草台湾妹   沒露臉的職業選手,這條微博的指向很明顯,很快便受到來自林徵羽粉絲的組團攻擊。热热撸影音先锋   一陣腳步聲傳來,有人上樓來了!   “臥槽,前面那個我也這麼覺得,我們該不會是一個學校吧哈哈......”日夜撸影音先锋   ***

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo